Stock Image

Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals: Workshop Summary

Medicine, Institute of; Policy, Board on Health Sciences; Forum on Drug Discovery, Development,; Translation

0 ratings by Goodreads
ISBN 10: 0309102766 / ISBN 13: 9780309102766
Published by National Academies Press 2007-04-12, 2007
New Condition: New Soft cover
Buy New
List Price: US$ 29.00
Price: US$ 24.22 Convert Currency
Shipping: US$ 1.00 Within U.S.A. Destination, Rates & Speeds
Add to basket

30 Day Return Policy

Offered By

DontPayMore
Lindenhurst, NY, U.S.A.

5-star rating

AbeBooks Seller Since October 24, 2008

About this Item

0309102766 New Condition. Ships immediately. Bookseller Inventory # Z0309102766ZN

Quantity Available: 1

Ask Seller a Question

Bibliographic Details

Title: Adverse Drug Event Reporting: The Roles of ...

Publisher: National Academies Press 2007-04-12

Publication Date: 2007

Binding: Paperback

Book Condition: New

Edition: 1.

About this title

Synopsis:

Recent concerns about the unexpected adverse effects of marketed drugs, such as COX-2 (cyclooxygenase-2) inhibitors or specific statins, raise concerns not only about reporting these events during premarket studies, but also about the responsibility for ongoing surveillance of drugs once they are on the market. Sometimes serious adverse drug reactions are fully appreciated only after a drug has been on the market for years. Therefore, when a drug is approved and released to the market, large numbers of patients will be exposed before all the potential adverse effects have been identified and thoroughly studied. Currently, there is no clearly defined process for addressing safety questions about drugs after premarketing research has occurred.

In November 2005, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation convened a workshop to explore issues associated with the reporting of ADEs. The workshop addressed the following questions: How can ADEs be effectively identified, particularly when the adverse effects are rare? How can the direct, causal effects of drugs be distinguished from simple associations? How can health-care professionals and their patients' aid in the identification of drug-related adverse events? How can knowledge of ADEs be more effectively used in clinical practice?

Adverse Drug Event Reporting reviews current sources of information on adverse drug events, including the FDA's MedWatch program and the AERS, institutional review boards, and the CMS. This report considers the ways that consumers and advocacy groups can be involved in reporting adverse events, and discusses drug interactions, problems with current databases for capturing and evaluating interactions, and difficulties in communicating information about adverse drug interactions. This report also describes new requirements for information contained on drug labels and how labels can be used to communicate information about risks and drug interactions to consumers and practitioners.

About the Author:

Forum on Drug Discovery, Development, and Translation, Jeffrey M. Drazen, Jennifer Rainey, Heather Begg, and Adrienne Stith Butler, Rapporteurs

"About this title" may belong to another edition of this title.

Store Description

Visit Seller's Storefront

Terms of Sale:

business as an individual information:

 first and last name    Jon Nikrav
 your address           10 sagamore street plainview ny 11803
 email address   whypaymorebooks@gmail.com 
 fax number      631 412 5027

Shipping Terms:

Orders ship within 1 business day.

List this Seller's Books

Payment Methods
accepted by seller

Visa Mastercard American Express